CardioGenics Holdings Inc
OTC:CGNH
CardioGenics Holdings Inc
OTC:CGNH
Price:
0.0001
USD
Market Cap:
$9.6k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
CardioGenics Holdings Inc
OTC:CGNH
|
US |
|
Eurocell PLC
LSE:ECEL
|
UK |
|
G
|
Golden Heaven Group Holdings Ltd
NASDAQ:GDHG
|
CN |
|
M. J. International Co Ltd
TWSE:8466
|
TW |
|
B
|
Bursa Malaysia Bhd
KLSE:BURSA
|
MY |
|
All for One Group SE
XETRA:A1OS
|
DE |
|
Generation Income Properties Inc
NASDAQ:GIPR
|
US |
|
G
|
GP Industries Ltd
SGX:G20
|
SG |
|
MCC Meili Cloud Computing Industry Investment Co Ltd
SZSE:000815
|
CN |
|
Ifa Systems AG
XETRA:IS8
|
DE |
|
Jubilant Industries Ltd
NSE:JUBLINDS
|
IN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of CGNH.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CGNH
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
CGNH Competitors Multiples
CardioGenics Holdings Inc Competitors
CardioGenics Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
CardioGenics Holdings Inc
OTC:CGNH
|
9.6k USD | 0 | -0 | -0.5 | -0.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 87.3 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5 | 24 | 14 | 14 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.3 | 21.2 | 22.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.4 | 15.3 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
